Cafepharma Today

May 13 2025 - GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
Bluebird bio warns of potential bankruptcy after another buyout delay
HIV market expected to reach $32.1bn by 2033 in 7MM
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications
Pharma Voice
Thursday, May 8, 2025 - 10:57am
tags:
Alnylam, Rare Diseases, RNAi, R&D
The math of biotech VC is about to change
Axios
Thursday, May 8, 2025 - 10:55am
tags:
FDA, Vinay Prasad, biotech, venture capital
Shionogi aims to buy tobacco giant's pharma unit for $1bn
Pharmaphorum
Thursday, May 8, 2025 - 10:53am
tags:
Shionogi, M&A, Torli Pharma, Japan Tobacco
Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase
Fierce Pharma
Thursday, May 8, 2025 - 10:51am
tags:
Teva Pharmaceutical, layoffs, restructuring
US judge sides with FDA's removal of Lilly's weight loss drug from shortage list
MSN/Reuters
Wednesday, May 7, 2025 - 11:05pm
tags:
FDA, Eli Lilly, Zepbound, Mounjaro, drug shortages
Gilead boosts planned US investments by $11 billion amid tariff threat
Yahoo/Reuters
Wednesday, May 7, 2025 - 11:01pm
tags:
Gilead Sciences, tariffs, drug manufacturing
Masimo Sells Sound United for $350M
Medical Devices and Diagnostics Industry
Wednesday, May 7, 2025 - 10:56pm
tags:
Medtech, Masimo
FDA set to meet this month on COVID vaccines
BioPharma Dive
Wednesday, May 7, 2025 - 10:54pm
tags:
FDA, adcomm, vaccines, COVID-19
Vivo Capital secures $740M to invest in preclinical and clinical-stage biotechs
Fierce Biotech
Wednesday, May 7, 2025 - 10:52pm
tags:
Vivo Capital, funding
Novo's Wegovy takes a hit from compounders, but company expects faster second-half growth
Fierce Pharma
Wednesday, May 7, 2025 - 11:46am
tags:
Novo Nordisk, Wegovy, earnings
Charles River Labs stock soars as firm shakes up board, launches review
Yahoo Finance
Wednesday, May 7, 2025 - 11:44am
tags:
Charles River Laboratories, Elliott Management
Teva Pharmaceutical’s branded drugs boost first quarter profit
Investing.com
Wednesday, May 7, 2025 - 11:31am
tags:
Teva Pharmaceutical, earnings
Vertex shrugs off Q1 miss with ‘strong’ Journavx launch, encouraging pipeline position
BioSpace
Wednesday, May 7, 2025 - 11:27am
tags:
Vertex Pharmaceuticals, earnings, Journavx
Sarepta tries to quell concerns over DMD gene therapy Elevidys as patients delay treatment after death report
Fierce Pharma
Wednesday, May 7, 2025 - 11:25am
tags:
Sarepta Therapeutics, DMD, Duchenne Muscular Dystrophy, earnings, Elevidys, gene therapy
CRISPR Therapeutics sees 80% fall in LDL, triglycerides after in vivo liver editing
Fierce Biotech
Wednesday, May 7, 2025 - 11:23am
tags:
CRISPR Therapeutics, CRISPR, gene editing, CTX310, LDL cholesterol
With TV ads under threat, here’s how pharma can leverage social media
Pharma Voice
Wednesday, May 7, 2025 - 11:18am
tags:
pharma advertising, television ads, DTC ads, social media, Robert F Kennedy Jr.
New data could move Enhertu into early breast cancer
Pharmaphorum
Wednesday, May 7, 2025 - 11:15am
tags:
AstraZeneca, Daiichi Sankyo, Enhertu, clinical trials, early breast cancer, breast cancer
Neurocrine hands back 2 CNS gene therapy programs to Voyager
Fierce Biotech
Wednesday, May 7, 2025 - 11:13am
tags:
Neurocrine Biosciences, gene therapy, Voyager Therapeutics, CNS
Theriva Biologics announces positive VIRAGE phase 2b results
Tip Ranks
Wednesday, May 7, 2025 - 11:11am
tags:
Theriva Biologics, VCN-01, pancreatic cancer, clinical trials
A Most Flawed Notion: Medicaid "Fix" Will Worsen 340B Crisis
Forbes
Wednesday, May 7, 2025 - 11:08am
tags:
340B, most favored nation, Donald Trump, Medicaid

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline
Treating Orthopox Viruses - With What?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.